Most gene therapy research to date has focused on solving the delivery prob
lem - getting genes efficiently and stably into target cells and tissues. T
hose working on systems for regulating the expression of genes once deliver
ed have often been accused of trying to run before they can walk. Yet regul
ation is likely to be essential if gene therapy is to realize its full pote
ntial as a mainstream clinical option for delivering proteins. Dramatic pro
gress has been made in designing and testing systems in which expression is
controlled by orally active drugs. The next few years should see the first
clinical trials of drug-regulated gene therapies.